이식형 제세동기(ICD) 시장 : 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global implantable cardioverter defibrillator (ICD) market size is expected to reach USD 8.14 Billion in 2034 from USD 4.48 Billion in 2025, growing at a CAGR of 6.86 during 2026-2034.This market is expanding rapidly due to the rising incidence of life-threatening cardiac arrhythmias and sudden cardiac arrest. Implantable cardioverter defibrillators are critical devices that monitor heart rhythms and deliver electrical shocks when necessary to restore normal function. Increasing awareness about cardiac health and advancements in medical technology are key factors driving market growth.

Technological innovations are leading to the development of smaller, more efficient, and longer-lasting ICD devices. Features such as remote monitoring and improved diagnostic capabilities are enhancing patient care. The growing aging population and increasing healthcare expenditure are further supporting market expansion. Hospitals and cardiac care centers are increasingly adopting advanced devices to improve treatment outcomes.

In the future, the ICD market is expected to benefit from advancements in minimally invasive procedures and integration with digital health technologies. Continuous research and development will lead to more efficient and patient-friendly devices. As cardiovascular diseases remain a major global concern, the demand for ICDs is projected to grow steadily.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product Type

• Transvenous Implantable Cardioverter-Defibrillators
• Subcutaneous Implantable Cardioverter Defibrillators

By Type

• Single Chamber ICDs
• Dual Chamber ICDs
• Biventricular Devices

By NYHA Class

• NYHA Class II
• NYHA Class III

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Abbott, Medtronic, Biotronik SE & Co. KG, Boston Scientific Corporation, MicroPort Scientific Corporation., LivaNova PLC

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Transvenous Implantable Cardioverter-Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Subcutaneous Implantable Cardioverter Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Type
• 5.2. Single Chamber ICDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Dual Chamber ICDs Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Biventricular Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY NYHA CLASS 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Nyha Class
• 6.2. NYHA Class II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. NYHA Class III Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY END USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End Use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Type
  • 8.2.3 By Nyha Class
  • 8.2.4 By End Use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Type
  • 8.3.3 By Nyha Class
  • 8.3.4 By End Use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Type
  • 8.4.3 By Nyha Class
  • 8.4.4 By End Use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Type
  • 8.5.3 By Nyha Class
  • 8.5.4 By End Use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Type
  • 8.6.3 By Nyha Class
  • 8.6.4 By End Use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott
  • 10.2.2 Medtronic
  • 10.2.3 Biotronik SE & Co. KG
  • 10.2.4 Boston Scientific Corporation
  • 10.2.5 MicroPort Scientific Corporation
  • 10.2.6 LivaNova PLC